VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis
Clinical trial NCT05655299 · TERMINATED
Trial details
- NCT number
- NCT05655299
- Sponsor
- Ventyx Biosciences, Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-17
- Primary completion
- 2023-09-25
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.